2003
DOI: 10.1016/s1570-0232(02)01017-6
|View full text |Cite
|
Sign up to set email alerts
|

Optimization of a solid-phase extraction method for determination of indapamide in biological fluids using high-performance liquid chromatography

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
27
0

Year Published

2003
2003
2015
2015

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 32 publications
(27 citation statements)
references
References 7 publications
0
27
0
Order By: Relevance
“…Sample preparation and clean-up must be carried out on these biological fluids before determination of antidepressant drugs by gas chromatography (GC) or high-performance liquid chromatography (HPLC). Several sample preparation methods for the determination of drugs in human fluids have been reported [4][5][6][7][8][9][10].…”
Section: Introductionmentioning
confidence: 99%
“…Sample preparation and clean-up must be carried out on these biological fluids before determination of antidepressant drugs by gas chromatography (GC) or high-performance liquid chromatography (HPLC). Several sample preparation methods for the determination of drugs in human fluids have been reported [4][5][6][7][8][9][10].…”
Section: Introductionmentioning
confidence: 99%
“…The methods reported in literature for estimation of indapamide in whole blood [6,[8][9][10][11][12], serum [8,13,14], plasma [11,12], and urine [11,[15][16][17][18][19] involves use of HPLC, or in combination with MS, i.e. LC-MS/MS analytical techniques.…”
Section: Introductionmentioning
confidence: 99%
“…These methods had LLOQ between 1.0 and 50.0 ng/ml, applicable for 2.5 mg, 5.0 mg of immediate release and 1.5 mg of sustainedrelease formulations. Many of these methods [8][9][10][11]14], however, do not meet some of the modern drug-development needs with respect to efficient extraction procedure, throughput or sufficient sensitivity. The capability of a single analytical method that encompasses all of the above merits to monitor the total absorption, distribution and elimination pharmacokinetic profile of the pre-clinical and clinical pharmacokinetic studies especially with low-dose sustained-release formulations is of prime concern.…”
Section: Introductionmentioning
confidence: 99%
“…Although the assay of indapamide in pharmaceutical formulations and determination of the related substances profile is frequently referred in literature, using spectrometric and chromatographic [4][5][6][7] methods, only very few HPLC/UV methods were dedicated to its determination in biological fluids [8][9][10].…”
Section: Introductionmentioning
confidence: 99%